Zhang L, Liu S, Zhao Q, Liu X, Liu T, Zhang Q
World J Hepatol. 2025; 17(2):102328.
PMID: 40027566
PMC: 11866134.
DOI: 10.4254/wjh.v17.i2.102328.
Li J, Nagasaka Y, Shen H, Zhou X, Ma J, Trevisan-Silva D
Mol Ther Nucleic Acids. 2025; 36(1):102460.
PMID: 39995975
PMC: 11848774.
DOI: 10.1016/j.omtn.2025.102460.
Gutierrez Cruz A, Borhani Peikani M, Beaulac T, Mutafova-Yambolieva V
Int J Mol Sci. 2025; 26(1.
PMID: 39795990
PMC: 11720413.
DOI: 10.3390/ijms26010131.
Niazi A, Kim J, Kim D, Lu D, Sterin I, Park J
Dev Cell. 2024; 60(5):679-695.e8.
PMID: 39657673
PMC: 11905117.
DOI: 10.1016/j.devcel.2024.11.011.
Lemmex A, Allred J, Ostergard J, Trask J, Bui H, Anderson M
bioRxiv. 2024; .
PMID: 39484510
PMC: 11526928.
DOI: 10.1101/2024.10.22.617501.
Development of a Proteomic Workflow for the Identification of Heparan Sulphate Proteoglycan-Binding Substrates of ADAM17.
Calligaris M, Spano D, Puccio M, Muller S, Bonelli S, Lo Pinto M
Proteomics. 2024; 24(23-24):e202400076.
PMID: 39318062
PMC: 11648071.
DOI: 10.1002/pmic.202400076.
Adamts9 is required for the development of primary ovarian follicles and maintenance of female sex in zebrafish†.
Carver J, Amato C, Hung-Chang Yao H, Zhu Y
Biol Reprod. 2024; 111(5):1107-1128.
PMID: 39180722
PMC: 11565245.
DOI: 10.1093/biolre/ioae127.
Cleavage site-directed antibodies reveal the prion protein in humans is shed by ADAM10 at Y226 and associates with misfolded protein deposits in neurodegenerative diseases.
Song F, Kovac V, Mohammadi B, Littau J, Scharfenberg F, Matamoros Angles A
Acta Neuropathol. 2024; 148(1):2.
PMID: 38980441
PMC: 11233397.
DOI: 10.1007/s00401-024-02763-5.
A methodology to globally assess ectodomain shedding using soluble fractions from the mouse brain.
Lobete M, Salinas T, Izquierdo-Bermejo S, Socas S, Oset-Gasque M, Martin-de-Saavedra M
Front Psychiatry. 2024; 15:1367526.
PMID: 38962061
PMC: 11219901.
DOI: 10.3389/fpsyt.2024.1367526.
Targeting a disintegrin and metalloprotease (ADAM) 17-CD122 axis enhances CD8 T cell effector differentiation and anti-tumor immunity.
Sun L, Jiao A, Liu H, Ding R, Yuan N, Yang B
Signal Transduct Target Ther. 2024; 9(1):152.
PMID: 38918390
PMC: 11199508.
DOI: 10.1038/s41392-024-01873-6.
Ectodomain shedding of PLA2R1 is mediated by the metalloproteases ADAM10 and ADAM17.
Dolla G, Nicolas S, Dos Santos L, Bourgeois A, Pardossi-Piquard R, Bihl F
J Biol Chem. 2024; 300(7):107480.
PMID: 38897568
PMC: 11301074.
DOI: 10.1016/j.jbc.2024.107480.
The Alzheimer's disease-linked protease BACE2 cleaves VEGFR3 and modulates its signaling.
Schmidt A, Hrupka B, van Bebber F, Sunil Kumar S, Feng X, Tschirner S
J Clin Invest. 2024; 134(16).
PMID: 38888964
PMC: 11324312.
DOI: 10.1172/JCI170550.
The proteome of Nicotiana benthamiana is shaped by extensive protein processing.
Zheng K, Lyu J, Thomas E, Schuster M, Sanguankiattichai N, Ninck S
New Phytol. 2024; 243(3):1034-1049.
PMID: 38853453
PMC: 11494411.
DOI: 10.1111/nph.19891.
Cryo-EM reveals that iRhom2 restrains ADAM17 protease activity to control the release of growth factor and inflammatory signals.
Lu F, Zhao H, Dai Y, Wang Y, Lee C, Freeman M
Mol Cell. 2024; 84(11):2152-2165.e5.
PMID: 38781971
PMC: 11248996.
DOI: 10.1016/j.molcel.2024.04.025.
Proteolysis in plant immunity.
Liu Y, Jackson E, Liu X, Huang X, van der Hoorn R, Zhang Y
Plant Cell. 2024; 36(9):3099-3115.
PMID: 38723588
PMC: 11371161.
DOI: 10.1093/plcell/koae142.
Targeted therapy for multiple myeloma: an overview on CD138-based strategies.
Riccardi F, Tangredi C, Dal Bo M, Toffoli G
Front Oncol. 2024; 14:1370854.
PMID: 38655136
PMC: 11035824.
DOI: 10.3389/fonc.2024.1370854.
Novel Potential Therapeutic Targets in Autosomal Dominant Polycystic Kidney Disease from the Perspective of Cell Polarity and Fibrosis.
Ahn Y, Park J
Biomol Ther (Seoul). 2024; 32(3):291-300.
PMID: 38589290
PMC: 11063481.
DOI: 10.4062/biomolther.2023.207.
iRhom2 regulates ectodomain shedding and surface expression of the major histocompatibility complex (MHC) class I.
Calligaris M, Spano D, Bonelli S, Muller S, Carcione C, Dapolito D
Cell Mol Life Sci. 2024; 81(1):163.
PMID: 38570362
PMC: 10991058.
DOI: 10.1007/s00018-024-05201-7.
MicroRNAs and proteolytic cleavage of receptors in cancers: A comprehensive review of regulatory interactions and therapeutic implications.
Hosseinpour-Soleimani F, Salmasi Z, Ghasemi Y, Tajbakhsh A, Savardashtaki A
Heliyon. 2024; 10(7):e28167.
PMID: 38560206
PMC: 10979173.
DOI: 10.1016/j.heliyon.2024.e28167.
Glycosaminoglycan modifications of betaglycan regulate ectodomain shedding to fine-tune TGF-β signaling responses in ovarian cancer.
Choi A, Jenkins-Lane L, Barton W, Kumari A, Lancaster C, Raulerson C
Cell Commun Signal. 2024; 22(1):128.
PMID: 38360757
PMC: 10870443.
DOI: 10.1186/s12964-024-01496-y.